WO2014202234A1

WO2014202234A1 - Water-free compositions

Info

Publication number: WO2014202234A1
Application number: PCT/EP2014/052047
Authority: WO
Inventors: Thomas Döring
Original assignee: Henkel Ag & Co. Kgaa
Priority date: 2013-06-17
Filing date: 2014-02-03
Publication date: 2014-12-24
Also published as: DE102013211312A1

Abstract

Solid, water-free compositions, especially in the shape of a molded product, containing at least one fatty alcohol with 12 to 18 carbon atoms, at least one fatty alcohol with more than 18 carbon atoms, at least one lactone compound of formula (I), wherein R represents a hydrocarbon group with 5 to 19 carbon atoms, are particularly suitable for the gentle and mild application to a substrate, such as skin.

Description

"Anhydrous compositions"

The present invention relates to cosmetics, in particular anhydrous compositions which are present as shaped bodies and act as skin cosmetics.

Cosmetics are available in various forms of application. An important form of application is solid-form cosmetics. The application of cosmetics in solid form offer various advantages. Compared with a spray application or even against the application of liquid to slightly viscous compositions, solid compositions, in particular if they are present as shaped bodies, can be applied specifically to the desired location of the substrate.

Said solid-form cosmetics are known to the person skilled in the art, for example, as lipstick, deodorant, antiperspirant or make-up stick. For example, body odor compositions are an important part of daily personal hygiene. They should ensure that the sweat produced during the day through various activities (physical activity, work, sports) as well as psychological stress does not lead to an unpleasant body odor. Just as diverse as the components of sweat and the causes of the development of body odor are the deodorants of commercial deodorants. Suitable odor absorbers, fragrances, deodorizing ion exchangers, germ-inhibiting agents, prebiotic components and enzyme inhibitors can be used as cosmetic deodorizing agents. Body odor is, in simplified terms, due to the bacterial decomposition of the organic components of perspiration. In turn, some of the bacteria responsible for the natural microflora of human skin are responsible for bacterial degradation, especially Gram-positive anaerobic cocci, e.g. Staphylococci, such as Staphylococcus hominis, and corynebacteria. Since the body odor is caused by bacterial activity, it can be particularly effectively prevented by the use of cosmetic agents (soaps, creams, powders, sticks, rollers, gels or sprays) containing antimicrobial substances and perfume oil compositions. As antimicrobial agents, triclosan and chlorhexidine are used to produce deodorants, among others. Furthermore, essential oils such as clove oil (eugenol), peppermint oil (menthol) and thyme oil (thymol) are used as active ingredients for deodorants, although the pronounced inherent odor of these compounds has a dose-limiting effect. As organochlorine compound, triclosan is ecologically undisputed. Essential oils have a relatively high allergenic potential, which, in addition to their own odor, limits their use. Aromatic alcohols, such as, for example, 2-methyl-5-phenylpentan-1-ol, 2-phenylethan-1-ol or 3-phenylpropan-1-ol, are already known in the art as antimicrobial and deodorizing agents. These Compounds are highly effective, at the same time very skin-friendly, and have only a weak odor.

When applying solid compositions to a substrate, especially when these solid form compositions are in the form of shaped bodies, the composition is rubbed on the substrate, e.g. the skin, a portion of the solid composition dissolved from the composite and deposited on the substrate. The friction may cause irritation of the substrate, e.g. a skin irritation, trigger what is felt, for example, in the case of skin irritation as unpleasant. If the substrate is sensitive to friction, e.g. Skin (especially already irritated skin) should the solid composition have a soft and creamy texture but still be mechanically stable. This is especially true when the solid-shaped composition is present as a shaped body.

It was therefore an object of the present invention to provide solid compositions which can be deposited on a substrate and do not impair the substrate by the friction required for this purpose. When the substrate is skin, the solid composition is said to impart a soft feel to the skin. When applying the solid composition to the skin, it should not be irritated by friction. The solid composition, especially when present as a shaped article, should have no or at least reduced syneresis (e.g., at elevated temperature or under pressure).

It has been found that the stated object is achieved by the following first subject matter of the invention: Solid, anhydrous composition, in particular in the form of a molding, containing

at least one fatty alcohol having 12 to 18 carbon atoms,

at least one fatty alcohol with more than 18 carbon atoms,

at least one lactone compound of the formula I

wherein R is a hydrocarbon radical having 5 to 19 carbon atoms.

All information on the states of aggregation of the starting materials used (solid, liquid, etc.) in this application refers to standard conditions. "Normal conditions" in the context of the present application are a temperature of 20 ° C. and a pressure of 1013.25 mbar also at a pressure of 1013.25 mbar.

The term "anhydrous" according to the invention is understood to mean that the compositions contain 0 to a maximum of 3% by weight, preferably 0 to a maximum of 2% by weight, of free water, based on the total composition. The content of water of crystallization, water of hydration or similar molecularly bound water, which in the constituents used, in particular in optionally contained antiperspirant active ingredients may be contained, does not constitute free water for the purposes of the present application.

The moldings according to the invention can take any geometric shape, such as concave, convex, biconcave, biconvex, cubic, tetragonal, orthorhombic, cylindrical, spherical, cylinder segment, disk-shaped, tetrahedral, dodecahedral, octahedral, conical, pyramidal, ellipsoidal, pentagonal, hexagonal, octagonal, prismatic, and rhombohedral shapes Preferred moldings have a cylindrical shape, with the area of a cut made at 90 ° through the cylinder height having three to infinite corners. Said cylinder section surface is particularly preferably circular or elliptical, and most preferably the shaped element has an elliptical cylinder section surface.

According to the invention, fatty alcohols are understood as meaning primary alcohols in the form of monohydroxy compounds of a linear, aliphatic hydrocarbon, said hydrocarbon having at least 12 carbon atoms and having no further substituents besides the hydroxy group.

The composition of the invention necessarily contains a defined mixture of fatty alcohols.

It is inventively preferred if the fatty alcohols used to prepare the composition of the invention are present as a solid and all definitions relating to fatty alcohols refer to solid fatty alcohols in the context of the application and liquid fatty alcohols are attributed exclusively to the oil component of the composition according to the invention.

Such compositions have been found to be preferred, in which the term "fatty alcohol of 12 to 18 carbon atoms" refers to saturated fatty alcohol of 12 to 18 carbon atoms.

It is inventively preferred if the composition based on their total weight fatty alcohol having 12 to 18 carbon atoms in a total amount of 12 to 25 wt .-%, in particular 15 to 20 wt .-%, contains. Again, it is preferred that the term "fatty alcohol of 12 to 18 carbon atoms" refers to saturated fatty alcohol of 12 to 18 carbon atoms.

A total amount of stearyl alcohol, based on the total weight of the composition, of from 12 to 25% by weight, in particular from 15 to 20% by weight, is very particularly preferred.

An inventively particularly preferred fatty alcohol having more than 18 carbon atoms is selected from arachidyl alcohol and / or behenyl alcohol. Particularly preferred compositions are characterized in that the total amount of fatty alcohol with more than 18 carbon atoms, based on the total weight of the composition, from 0.005 to 1 wt .-%, in particular 0.05 to 0.2 wt .-%, is.

Independently of this, it is preferred if the weight ratio of the (especially solid) fatty alcohols having 12 to 18 carbon atoms to the (especially solid) fatty alcohols having more than 18 carbon atoms in a weight ratio range of 500: 1 to 50: 1, in particular 300: 1 to 100 to 1, lies.

The compound according to formula (I) contained in preferred compositions of the invention carries the INCI name Meadowfoam delta-lactones.

Particularly preferred compositions are characterized by a total amount of the compounds according to formula (I) of from 0.05 to 5.0% by weight, in particular from 0.1 to 0.5% by weight, based on the total weight of the composition.

Within the scope of a preferred embodiment of the invention, the compositions according to the invention additionally contain at least one antiperspirant active ingredient, which is also referred to as antiperspirant active ingredient.

Particularly preferred compositions according to the invention are characterized in that the at least one antiperspirant active ingredient is present in an amount of 3 to 35% by weight, preferably 5 to 30% by weight and more preferably 10 to 23% by weight on the total weight of the anhydrous active substance (USP) in the total composition.

Preferred antiperspirant active ingredients are selected from the water-soluble astringent inorganic and organic salts of aluminum, zirconium and zinc or any desired mixtures of these salts.

According to the invention, water solubility is understood as meaning a solubility of at least 5% by weight at 20 ° C., that is to say amounts of at least 5 g of the antiperspirant active are soluble in 95 g of water at 20 ° C.

Particularly preferred antiperspirant active ingredients are selected from aluminum chlorohydrate, in particular aluminum chlorohydrate having the general formula [Al ₂ (OH) ₅ ^Cl. 1-6 H ₂ O] _n , preferably [Al ₂ (OH) ₅ ^Cl. 2-3 H ₂ O. ] _n , which may be in non-activated or in activated (depolymerized) form, and aluminum chlorohydrate having the general formula [Al ₂ (OH) ₄ Cl ₂ ^■ 1-6 H ₂ O] _n , preferably [Al ₂ (OH) ₄ CI ₂ ^■ 2-3 H ₂ O] _n , which may be in unactivated or in activated (depolymerized) form.

The preparation of preferred antiperspirant agents is disclosed, for example, in US 3887692, US 3904741, US 4359456, GB 2048229 and GB 1347950. Also preferred are aluminum sesquichlorohydrate, aluminum dichlorohydrate, aluminum chlorohydrex-propylene glycol (PG) or aluminum chlorohydrex-polyethylene glycol (PEG), aluminum or aluminum zirconium glycol complexes, e.g. Aluminum or aluminum zirconium-propylene glycol complexes, aluminum sesquichlorohydrex PG or aluminum sesquichlorohydrex PEG, aluminum PG-dichlorhydrex or aluminum PEG-dichlorhydrex, aluminum hydroxide further selected from the aluminum zirconium chlorohydrates such as aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate, aluminum zirconium octachloro hydrate, aluminum-zirconium chlorohydrate glycine complexes, such as Aluminiumzirconiumtrichlor- hydrexglycin, Aluminiumzirconiumtetrachlorhydrexglycin, Aluminiumzirconiumpentachlor- hydrexglycin, Aluminiumzirconiumoctachlorhydrexglycin, potassium aluminum sulfate (KAI (S0 ₄₎ ₂ ^■ 12 H ₂ 0, alum), Aluminiumundecylenoylcollagenaminosäure, Natriumaluminiumlactat + aluminum sulfate, sodium aluminum, Aluminum bromohydrate, aluminum chloride, the complexes of zinc and sodium salts, the complexes of lanthanum and cerium, the aluminum salts of lipoamino acids, aluminum sulph fat, aluminum lactate, aluminum chlorhydroxyallinate, sodium aluminum chlorohydroxy lactate, zinc chloride, zinc sulfocarbolate, zinc sulfate, zirconium oxyhalides, in particular zirconyl oxychlorides, zirconyl hydroxy halides, in particular zirconyl hydroxychlorides (zirconium chlorohydrate).

Antiperspirant active ingredients which are particularly preferred according to the invention are selected from what are known as "activated" aluminum and aluminum zirconium salts, which are also referred to as "enhanced activity" as antiperspirant active ingredients. Such agents are known in the art and are also commercially available. Their preparation is disclosed, for example, in GB 2048229, US 4775528 and US 6010688. Activated aluminum and aluminum-zirconium salts are typically produced by heat treating a relatively dilute solution of the salt (e.g., about 10% by weight of salt) to increase its HPLC peak 4-to-peak 3 area ratio. The activated salt can then be dried to a powder, in particular spray-dried. In addition to the spray drying z. B. also suitable for drum drying.

Activated aluminum and aluminum zirconium salts typically have an HPLC peak 4 to peak 3 area ratio of at least 0.4, preferably at least 0.7, more preferably at least 0.9, with at least 70% of the aluminum attributable to these peaks ,

Activated aluminum and aluminum zirconium salts do not necessarily have to be used as a spray-dried powder. Antiperspirant active ingredients which are likewise preferred according to the invention are nonaqueous solutions or solubilisates of an activated aluminum or aluminum zirconium antiperspirant salt, for example according to US 6010688, by adding an effective amount of a polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups , preferably propylene glycol, sorbitol and pentaerythritol, are stabilized against the loss of activation against the rapid degradation of the HPLC peak 4: peak 3 area ratio of the salt. For example, preferred are compositions which are described in Percent by weight (USP) contains: 18-45% by weight of an activated aluminum or aluminum zirconium salt, 55-82% by weight of at least one anhydrous polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups, preferably propylene glycol, Butylene glycol, diethylene glycol, dipropylene glycol, glycerol, sorbitol and pentaerythritol, particularly preferably propylene glycol.

Also particularly preferred are complexes of activated antiperspirant aluminum or aluminum-zirconium salts with a polyhydric alcohol containing 20-50% by weight, more preferably 20-42% by weight, activated antiperspirant aluminum or aluminum-zirconium salt, and 16 wt .-% molecularly bound water, the remainder to 100 wt .-% is at least one polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups. Propylene glycol, propylene glycol / sorbitol mixtures and propylene glycol / pentaerythritol mixtures are preferred such alcohols. Such inventively preferred complexes of an activated antiperspirant aluminum or aluminum zirconium salt with a polyhydric alcohol are, for. As disclosed in US 5643558 and US 6245325.

Further preferred antiperspirant active substances are basic calcium aluminum salts, as disclosed, for example, in US Pat. No. 2,571,030. These salts are prepared by reacting calcium carbonate with aluminum chlorhydroxide or aluminum chloride and aluminum powder or by adding calcium chloride dihydrate to aluminum chlorhydroxide.

Other preferred antiperspirant actives are aluminum-zirconium complexes as disclosed, for example, in US Pat. No. 4,017,599, which are buffered with salts of amino acids, in particular with alkali metal and alkaline earth glycinates.

Other preferred antiperspirant actives are activated aluminum or aluminum zirconium salts, such as disclosed in US 6,245,325 or US 6042816, containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in an amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1 to 1:10 and a water-soluble calcium salt in such an amount as to provide Ca: (AI + Zr) weight ratio of 1: 1-1: 28 and preferably 1: 2-1: 25. Particularly preferred solid activated antiperspirant salt compositions, for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight. %, preferably 4-13% by weight molecularly bound water (water of hydration), furthermore sufficient water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25, is and so much amino acid that the amino acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.

Further particularly preferred solid antiperspirant activated salt compositions, for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66 75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4-13% by weight of molecularly bound water (water of hydration), furthermore so much water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio 1: 1-1: 28, preferably 1: 2-1: 25, and so much glycine that the glycine to (Al + Zr) - weight ratio 2: 1-1: 20, preferably 1: 1 - 1: 10.

Further particularly preferred solid antiperspirant activated salt compositions, for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66

75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4-13% by weight of molecularly bound water, furthermore sufficient water-soluble calcium salt that the Ca: (Al + Zr) Weight ratio 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and as much hydroxyalkanoic that the hydroxyalkanoic acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10 , is.

Preferred water-soluble calcium salts for the stabilization of antiperspirant salts are selected from calcium chloride, calcium bromide, calcium nitrate, calcium citrate, calcium formate, calcium acetate, calcium gluconate, calcium ascorbate, calcium lactate, calcium glycinate, calcium carbonate, calcium sulfate, calcium hydroxide, and mixtures thereof.

Preferred amino acids for the stabilization of the antiperspirant salts are selected from glycine, alanine, leucine, isoleucine, β-alanine, valine, cysteine, serine, tryptophan, phenylalanine, methionine, β-amino-n-butanoic acid and γ-amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred.

Preferred hydroxyalkanoic acids for the stabilization of the antiperspirant salts are selected from glycolic acid and lactic acid.

Other preferred antiperspirant actives are activated aluminum or aluminum zirconium salts, such as disclosed in US 6902723, containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in one Amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20, and preferably 1: 1 to 1:10, and a water-soluble strontium salt in such an amount to give a Sr :( Al + Zr) - weight ratio of 1: 1 - 1: 28 and preferably 1: 2 - 1: 25 provide.

Particularly preferred solid antiperspirant activated salt compositions, for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 - 13 wt .-% molecularly bound water, further enough so much water-soluble strontium salt that the Sr: (AI + Zr) weight ratio 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and so much amino acid the amino acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is. Further particularly preferred solid antiperspirant activated salt compositions, for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 to 13% by weight of molecularly bound water, furthermore sufficient water-soluble strontium salt that the Sr: (Al + Zr) weight ratio is 1: 1 to 1:28, preferably 1: 2 to 1:25, and as much glycine, the glycine to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.

Further particularly preferred solid antiperspirant activated salt compositions, for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 to 13% by weight of molecularly bound water, furthermore sufficient water-soluble strontium salt, that the Sr: (Al + Zr) weight ratio is 1: 1 to 1:28, preferably 1: 2 to 1:25, and as much hydroxyl alkanoic acid that the hydroxyalkanoic acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.

Further preferred activated aluminum salts are those of the general formula Al ₂ (OH) ₆ . _a Xa, wherein X is Cl, Br, I or N0 ₃ and "a" is a value of 0.3 to 5, preferably from 0.8 to 2.5 and particularly preferably 1 to 2, so that the molar ratio of Al X is 0.9: 1 to 2, 1: 1, as disclosed, for example, in US 6074632. These salts generally associate some hydration water, typically 1 to 6 moles of water per mole of salt. Particularly preferred is aluminum chlorohydrate (ie, X is Cl in the aforementioned formula) and especially 5/6 basic aluminum chlorohydrate wherein "a" is 1 such that the molar ratio of aluminum to chlorine is 1.9: 1 to 2.1: 1 ,

Preferred activated aluminum-zirconium salts are those which are mixtures or complexes of the aluminum salts described above with zirconium salts of the formula ZrO (OH) ₂ _ _pb _b represent Y, wherein Y is Cl, Br, I, N0 ₃ or S0 _4, b is a rational number from 0.8 to 2 and p is the valence of Y, as disclosed, for example, in US 6074632. The zirconium salts also typically associate some hydration water associatively, typically 1 to 7 moles of water per mole of salt. Preferably, the zirconium salt is zirconyl hydroxychloride of the formula ZrO (OH) ₂ . _b Cl _b , wherein b is a rational number of 0.8 to 2, preferably 1, 0 to 1, 9. Preferred aluminum zirconium salts have an Al: Zr molar ratio of 2 to 10 and a metal: (X + Y) ratio of 0.73 to 1.2, preferably 0.9 to 1.5. A particularly preferred salt is aluminum-zirconium chlorohydrate (ie, X and Y are Cl) which has an Al: Zr ratio of 2 to 10 and a molar metal: Cl ratio of 0.9 to 2.1. The term aluminum-zirconium chlorohydrate includes the tri-, tetra-, penta- and octachlorohydrate forms.

Zirconium salts preferred according to the invention have the general formula ZrO (OH) ₂ . _a Cl _a ^■ x H ₂ 0 with a = 1.5 - 1 .87; x = 1-7, where a and x are rational numbers. These zirconium salts are disclosed, for example, in the Belgian specification BE 825146. Other preferred antiperspirant actives are disclosed in US 6663854 and US 20040009133.

The antiperspirant active ingredients can be present both in solubilized and in undissolved, suspended form.

If the antiperspirant active ingredients are suspended in a water-immiscible carrier, it is preferred for reasons of product stability that the active ingredient particles have a number-average particle size of 0.1 to 200 μm, preferably 1 to 50 μm, particularly preferably 3 to 20 μm, and extraordinarily preferably 5 - 10 μιη, have.

Preferred aluminum salts and aluminum zirconium salts have a molar metal-to-chloride ratio of 0.9-1.3, preferably 0.9-1.1, more preferably 0.9-1.0.

Preferred aluminum zirconium chlorohydrates generally have the empirical formula Al _n Zr (OH) _[ 3n ₊ 4-m (n ₊ i ₎ ] (CI) _[m (n ₊ i)] where n = 2.0-10.0 3.0 - 8, .0, m = 0.77 - 1, 1 1 (corresponding to a molar metal (Al + Zr) to chloride ratio of 1.3 to 0.9), preferably m = 0, 91-1.11 (corresponding to M: CI = 1.1.-0.9), and more preferably m = 1.00-1.1.1 (corresponding to M: CI = 1.0-0.9) very preferably m = 1, 02-1.1 (corresponding to M: CI = 0.98-0.9) and very preferably m = 1.4.10-1 (corresponding to M: CI = 0.96-0) , 9).

In general, some of the water of hydration is associatively bound to these salts, typically 1-6 moles of water per mole of salt, corresponding to 1-16% by weight, preferably 4-13% by weight of water of hydration.

Usually, the preferred aluminum zirconium chlorohydrates are associated with an amino acid to prevent polymerization of the zirconium species during manufacture. Preferred stabilizing amino acids are selected from glycine, alanine, leucine, isoleucine, β-alanine, cysteine, valine, serine, tryptophan, phenylalanine, methionine, β-amino-n-butanoic acid and γ-amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred. The amino acid is contained in the salt in an amount of 1 to 3 moles, preferably 1 to 3 to 1.8 moles, per mole of zirconium.

Preferred antiperspirant salts are aluminum-zirconium tetrachlorohydrate (Al: Zr = 2-6, M: CI = 0.9-1.3), in particular salts with a molar metal-to-chloride ratio of 0.9-1.1, preferably 0.9 - 1, 0.

Aluminiumzirconiumchlorohydrat-glycine salts with Betaine are still preferred in the invention ((CH ₃₎ ₃ N ⁺ -CH ₂ -COO ^") are stabilized. Particularly preferred corresponding compounds have a molar overall (Betaine + glycine) / Zr ratio of (0.1-3.0): 1, preferably (0.7-1.5): 1, and a betaine to glycine molar ratio of at least 0.001: 1. Corresponding compounds are disclosed, for example, in US 7105691.

In a particularly preferred embodiment of the invention is a particularly effective antiperspirant salt, a so-called "activated" salt, in particular one with a high HPLC peak 5-aluminum content, in particular with a peak 5 area of at least 33%, particularly preferably at least 45%, based on the total area under the peaks 2-5, measured by HPLC a 10 wt .-% strength aqueous solution of the active ingredient under conditions in which the aluminum species are resolved into at least 4 consecutive peaks (designated peaks 2-5). Preferred aluminum zirconium salts having a high HPLC peak 5-aluminum content (also referred to as "E ⁵ AZCH") are disclosed, for example, in US 6436381 and US 6649152.

Furthermore, those activated "E ⁵ AZC I salts are preferred whose HPLC peak 4-to-peak 3 area ratio of at least 0.4, preferably at least 0.7, more preferably at least 0.9.

Further particularly preferred antiperspirant active ingredients are those aluminum zirconium salts having a high HPLC peak 5-aluminum content, which are additionally stabilized with a water-soluble strontium salt and / or with a water-soluble calcium salt. Corresponding salts are disclosed, for example, in US Pat. No. 6,923,952.

Other preferred antiperspirant actives are selected from astringent titanium salts such as disclosed in GB 2299506A.

The antiperspirant active ingredients can be used as nonaqueous solutions or as glycolic solubilisates.

In a particularly preferred embodiment, the composition contains a adstringie- rendes aluminum salt, especially aluminum chlorohydrate, for example, in powder form as Micro Dry ^® Ultrafine or Super Ultrafine from Reheis, Microdry 323 of Summit, as Chlorhydrol ^® as well as in activated form as Reach ^® sold by Reheis 501 , Under the name ^Reach® 301 an aluminum sesquichlorohydrate from Reheis is offered, which is likewise particularly preferred. Particular preference is also activated aluminum chlorohydrates that are available under the names Reach ^® 101 and Reach ^® 103 Aach 7171 by Reheis or Summit are. The use of aluminum-zirconium-tetrachlorohydrex-glycine complexes, for example, by Reheis under the name Rezal ^® 36 GP of Reheis or AZG - 364 or 369 of Summit, in activated quality, as Reach ^® 908, as a powder in Trade, may be particularly preferred according to the invention. Aluminum-Zirkoniumpentachlorohydex-glycine complexes (AAZG-3108 or AAZG-31 10 from Summit) can also be used.

The composition according to the invention preferably additionally contains at least one oil. According to the invention, an oil is to be understood as meaning a liquid substance which is miscible under normal conditions in bidistilled water to less than 1% by weight.

It is inventively preferred if the composition according to the invention - in each case based on the total weight of the composition - oil in a total amount of 25 to 80 Wt .-%, particularly preferably from 30 to 70 wt .-%, most preferably from 40 to 60 wt.% Contains.

The composition according to the invention particularly preferably contains at least one volatile oil as oil. In this case, it is again preferred if the volatile oils - in each case based on the total weight of the composition - in a total amount of 25 to 80 wt .-%, particularly preferably from 30 to 70 wt .-%, most preferably from 30 to 55 wt .% Are contained in the composition of the invention.

According to the invention, volatile oil is understood as meaning oils having a vapor pressure of 0.01 kPa or more at 293.15 K.

Very particular preference is given to compositions according to the invention which comprise, as volatile oil, at least one volatile silicone oil and / or at least one C ₈ -C ₁₆ -silyl paraffin.

Oils preferred according to the invention are selected from silicone oils, to which z. Dialkyl and alkylaryl siloxanes such as cyclopentasiloxane, cyclohexasiloxane, dimethylpolysiloxane and methylphenylpolysiloxane, but also hexamethyldisiloxane, octamethyltrisiloxane and decamethyltetrasiloxane.

Particularly preferred volatile oils are volatile silicone oils and volatile non-silicone oils. Volatile silicone oils, which may be cyclic, such as. For example, octamethylcyclotetrasiloxane, decamethylcyclopenta- siloxane and mixtures thereof, as described, for. B. in the commercial products DC 244, 245, 344 and 345 of Dow Corning, are preferred according to the invention. Also particularly preferred are volatile linear silicone oils, in particular hexamethyldisiloxane (L ₂ ), octamethyltrisiloxane (L ₃ ), decamethyltetrasiloxane (L ₄ ) and any mixtures of two and three of L ₂ , L ₃ and / or L ₄ , preferably such mixtures as they z. In the commercial products DC 2-1 184, Dow ^Corning® 200 (0.65 cSt) and Dow ^Corning® 200 (1.5 cSt) from Dow Corning.

Volatile silicone oils are outstandingly suitable according to the invention since they give the composition according to the invention a pleasant feeling on the skin and a low level of clothes soiling. Compositions which are particularly preferred according to the invention are therefore characterized by a content of at least one volatile silicone oil. In this case, it is again preferred if the volatile silicone oils, based on the weight of the composition, in a total amount of from 25 to 80% by weight, particularly preferably from 30 to 70% by weight, very particularly preferably from 30 to 55% by weight, contained in the composition of the invention.

In addition to or instead of the at least one volatile silicone oil, it is also possible for at least one volatile non-silicone oil to be present. Preferred volatile non-silicone oils are selected from C ₈ -C ₆ -isoparaffins, in particular from isodecane, isododecane, isotetradecane and isohexadecane and mixtures thereof. In particular, C10-13 isoparaffin is preferred (eg commercial product Pioner 2094 from Hansen & Rosenthal). Because of the skin feel and stability of the resulting compositions, silicone oils are particularly preferred as the volatile oil over isoparaffins.

In addition to the aforementioned substances, commonly referred to as volatile silicone oils, as well as the aforementioned volatile non-silicone oils, the compositions of the present invention may additionally contain at least one non-volatile oil selected from nonvolatile silicone oils and non-volatile non-silicone oils.

Preferred nonvolatile silicone oils are selected from higher molecular weight linear dimethyl polysiloxanes, commercially available for. Example under the name Dow Corning ^® 190, Dow Corning ^® 200 fluid having kinematic viscosities (25 ° C) in the range from 5 to 100 cSt, preferably of 5 - 50 cSt or 5 - 10 cSt, and Baysilon ^® 350 M (with a kinematic viscosity (25 ° C) of about 350 cSt.

Nonvolatile silicone oils which are likewise preferred according to the invention are selected from silicones of the formula (Sil-1), where x is selected from integers of 1 to 20, preferably 1 to 3.

(Sil-1)

A preferred silicone oil of formula (Sil-1) is available under the INCI name Phenyl Trimethicone.

Natural and synthetic hydrocarbons such as paraffin oils, Ci fine ₈ -C ₃₀ -Isoparaf-, particularly isoeicosane, polyisobutenes or polydecenes, the ^®, for example, under the designation Emery ^® 3004, 3006, 3010 or under the name Ethylflo ^® from Albemarle or Nexbase 2004G available from Nestle are, as well as 1, 3-di- (2-ethylhexyl) -cyclohexane (obtainable, for. example, under the trade name Cetiol ^® S from Cognis) also belong to the present invention the preferred non-volatile non-silicone oils.

Further according to the invention preferred non-volatile non-silicone oils are selected from the benzoic acid esters of linear or branched C ₈ -22-alkanols. Particularly preferred are benzoic C12-C15 alkyl esters, z. B. available as a commercial product Finsolv ^® TN, benzoic isostearylester, z. B. available as a commercial product Finsolv ^® SB, ethylhexyl benzoate, z. B. available as a commercial product Finsolv ^® EB, and Benzoesäureoctyldocecylester, z. B. available as a commercial product Finsolv ^® BOD. Further according to the invention preferred non-volatile non-silicone oils are chosen from the triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C ₈ th _3 ₀ fatty acids. Particularly suitable may be the use of natural oils, for example soybean oil, cottonseed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, corn oil, rapeseed oil, olive oil, sesame oil, thistle oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil and the like. But are also synthetic triglyceride oils, in particular Capric / Caprylic triglycerides, z. As the commercial products Myritol ^® 318, Myritol ^® 331 (Cognis) or Miglyol ^® 812 (Hüls) with unbranched fatty acid residues and glyceryl triisostearin and the commercial products Estol ^® GTEH 3609 (Uniqema) or Myritol ^® GTEH (Cognis) with branched fatty acid residues.

Further according to the invention particularly preferred non-volatile non-silicone oils are selected from the dicarboxylic acid esters of linear or branched C ₂ -C ₀ -alkanols, in particular diisopropyl propyladipat, di-n-butyl adipate, di- (2-ethylhexyl) adipate, dioctyl adipate, diethyl / di- n-butyl / dioctyl sebacate, diisopropyl sebacate, dioctyl malate, dioctyl maleate, dicaprylyl maleate, diisooctyl succinate, di-2-ethylhexyl succinate and di- (2-hexyldecyl) succinate.

Further non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the esters of linear or branched saturated or nonvolatile non-silicone oils, esters of unsaturated alkanols having 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms which may be hydroxylated. These include, hexyldecyl stearate (Eutanol ^® G 16 S), hexyldecyl laurate, isodecyl neopentanoate, Isononylisonona- noat, 2-ethylhexyl palmitate (Cegesoft ^® C 24) and 2-ethylhexyl stearate (Cetiol ^® 868). Also preferably isopropyl palmitate, isopropyl stearate, isopropyl, isopropyl oleate, isooctyl, Isononylstearat, isocetyl stearate, isononyl isononanoate, isotridecyl isononanoate are, cetearyl, 2-ethylhexyl, 2-ethylhexyl, 2-ethylhexyl cocoate, 2-octyldodecyl, 2-butyl octanoic-butyl octanoate, Diisotridecylacetat , n-butyl stearate, n-hexyl laurate, n-decyl oleate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, ethylene glycol dioleate and dipalmitate.

Further inventively particularly preferred non-volatile non-silicone oils are selected from the addition products of 1 to 5 propylene oxide units of mono- or polyhydric C ₈ -22-alkanols such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg. B. PPG-2 myristyl ether and PPG-3 myristyl ether (Witconol APM ^®).

Further non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the adducts of at least 6 ethylene oxide and / or propylene oxide units with monovalent or polyvalent C ₃ . ₂ 2-alkanols such as glycerol, butanol, butanediol, myristyl alcohol and stearyl alcohol, which may be esterified if desired, for. As PPG-14 butyl ether (Ucon Fluid ^® AP), PPG-9-butyl ether (Breox B25 ^®), PPG-10 butanediol (Macol ^® 57), PPG-15 stearyl ether (Arlamol ^® E), and Glycereth-7 -diisononanoat. It is within the scope of this embodiment according to the invention particularly preferred when the composition contains at least one compound of formula (II)

R '- (O-CH ₂ CHMe) _m -H (II)

wherein R 'is a (C-C ₆ ) alkyl group and m is an integer from 5 to 20.

Further non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the C ₈ -C ₂ 2 -alkanol esters of monohydric or polyhydric C ₂ -C ₇ -hydroxycarboxylic acids, in particular the esters of glycolic acid, lactic acid, malic acid, tartaric acid, citric acid and salicylic acid. Such esters based on linear Ci _{4 /} i ₅ alkanols, eg. B. Ci ₂ -Ci ₅ -alkyllactate, and of branched in 2-position Ci2 / i3-alkanols are under the trademark Cosmacol ^® by Nordmann, Rassmann GmbH & Co, Hamburg, to obtain, in particular the commercial products Cosmacol ^® ESI, Cosmacol® ^® EMI and Cosmacol® ^® EIT.

Further inventively particularly preferred non-volatile non-silicone oils are selected from the symmetrical, asymmetrical or cyclic esters of carbonic acid with alkanols, eg. As glycerol carbonate, dicaprylyl (Cetiol ^® CC) or the esters according to the teaching of DE 19756454 A1.

Further oils which may be preferred according to the invention are selected from the esters of dimers of unsaturated C ₂ -C ₂ 2 -fatty acids (dimer fatty acids) with monovalent linear, branched or cyclic C ₂ -C ₈ -alkanols or with polyvalent linear or branched C ₂ -C ₆ -alkanols.

It is preferred according to the invention if the compositions according to the invention, based on the total weight of the composition, contain the nonvolatile oils in a total amount of from 0.1 to 25% by weight, in particular from 5 to 20% by weight.

It is within the scope of a further particularly preferred embodiment for solving the problem advantageous if the inventive composition

at least one volatile oil, preferably in a total amount of from 30 to 70% by weight, very particularly preferably from 30 to 55% by weight,

at least one non-volatile oil, preferably in a total amount of 0, 1 to 25 wt .-%, in particular from 5 to 20 wt .-%.

Again, this embodiment is most preferred when the composition contains at least one of the aforementioned preferred volatile oils and / or at least one of the preferred non-volatile oils.

Further preferred compositions according to the invention are characterized in that they additionally contain at least one solid, water-insoluble particulate filler, for example for improving the consistency and the sensory properties. In an extremely preferred embodiment, this filler is selected from optionally modified starches (eg from corn, rice, potatoes) and starch derivatives, if desired are pre-gelatinized (eg Dry FLO PC AKZO), silica, silicas, z. As Aerosil ^® types, spherical polyalkylsesquisiloxane particles (especially Aerosil ^® R972 and Aerosil ^® 200V from Degussa), silica gels, talc, kaolin, magnesium aluminum silicates, boron nitride, lactoglobulin derivatives, eg. B. Sodium C ₈ -i 6-lsoalkylsuccinyllactoglobulinsulfonat from Brooks Industries available as a commercial product Biopol ^® OE, glass powders, polymer powders, in particular of polyolefins, polycarbonates, polyurethanes, polyamides, z. As nylon, polyesters, polystyrenes, polyacrylates, (meth) acrylate or (meth) acrylate-vinylidene copolymers, which may be crosslinked, or silicones, and mixtures of these substances.

Polymer powder based on a polymethacrylate copolymer are z. B. available as a commercial product Polyrap ^® 6603 (Dow Corning). Other polymer powders, e.g. Example based on polyamides, obtainable under the name Orgasol ^® 1002 (polyamide-6) and Orgasol ^® 2002 (polyamide-12) from Elf Atochem. Other polymer powders which are suitable as inventively preferred fillers are, for. B. polymethacrylates (Micro Pearl ^® M from SEPPIC or Plastic Powder A of NIKKOL), styrene-divinylbenzene copolymers (Plastic Powder FP of NIKKOL), polyethylene and polypropylene powder (ACCUREL ^® EP 400 from AKZO), or silicone polymers (Silicone Powder X2-1605 from Dow Corning).

Preferred compositions according to the invention are characterized in that they contain at least one solid, water-insoluble particulate filler in a total amount of 1 to 99% by weight, preferably 2 to 90% by weight, more preferably 3 to 15% by weight, most preferably 4 , 5, 6, 7, 8, 9, 10, 1 1, 12, 13 and 14 wt .-%, each based on the total composition.

Further preferred compositions according to the invention are therefore characterized in that they additionally contain at least one lipophilic thickener.

Preferred lipophilic thickeners according to the invention are selected from hydrophobized clay minerals, fumed silicas, ethylene / propylene / styrene copolymers, butylene / ethylene / styrene copolymers, dextrin esters, silicone elastomers, solid waxes under normal conditions and / or glycerol triesters. Particularly preferably, the composition according to the invention additionally contains at least one silicone elastomer as the lipophilic thickener.

Preferred hydrophobized clay minerals are selected from hydrophobized montmorillonites, hydrophobized hectorites and hydrophobized bentonites, particularly preferably disteardimonium hectorites, stearalkonium hectorites, quaternium-18 hectorites and quaternium-18 bentonites. The commercially available thickeners provide these hydrophobic clay minerals in the form of a gel in an oil component, preferably in cyclomethicones and / or a non-silicone oil component such. As propylene carbonate, ready. Such gels are for example available under the trade name Bentone ^® or Thixogel. Compositions which are preferred according to the invention are characterized in that they contain at least one hydrophobized clay mineral in a total amount of 0.5-10% by weight, preferably 1-7% by weight, more preferably 2-6% by weight, most preferably 3%. 5 wt .-%, each based on the total weight of the composition according to the invention.

Further inventively preferred lipophilic thickeners are selected from pyrogenic silicas, eg. For example, the commercial products of the Aerosil ^® series from Evonik Degussa. Particular preference is given to hydrophobized pyrogenic silicas, with particular preference silica silylates and silica dimethyl silylates.

Preferred compositions according to the invention are characterized in that they contain at least one fumed silica, preferably at least one (preferably hydrophobized) fumed silica, in a total amount of 0.5-10% by weight, preferably 1-7% by weight, more preferably 2 - 6 wt .-%, most preferably 3 - 5 wt .-%, each based on the total weight of the composition according to the invention.

Further inventively preferred compositions are characterized in that they contain at least one hydrophobized fumed silica and at least one hydrophilic silica.

Further inventively preferred lipophilic thickeners are selected from ethylene / propylene / styrene copolymers and butylene / ethylene / styrene copolymers. Particularly preferred are the copolymers used as pre-thickened oil-based gel. Such gels are, for example, under the trade name Versagel ^® (ex Penreco) available. Gels with mineral oil, hydrogenated polyisobutene, isoparaffins, such as isohexadecane or isododecane, and with ester oils, in particular with isopropyl palmitate or isopropyl myristate, are preferred.

Compositions preferred according to the invention are characterized in that they contain at least one ethylene / propylene / styrene copolymer and / or butylene / ethylene / styrene copolymer in a total amount of 0.05-3% by weight, preferably 0.1-1% by weight. , Particularly preferably 0.2 to 1, 0 wt .-%, most preferably 0.3 to 0.5 wt .-%, each based on the total weight of the composition according to the invention.

Further inventively preferred lipophilic thickeners are selected from silicone elastomers. A further preferred embodiment of the invention is characterized in that at least one silicone elastomer which is available siloxane by the crosslinking of a Organopoly- that C _{2 is} at least 2 - Ci contains ₀ alkenyl groups with terminal double bond in each molecule, with an organopolysiloxane containing at least 2 silicon-bonded hydrogen atoms in each molecule.

According to the invention particularly preferred organopolysiloxanes having at least 2 C ₂ - C ₀ - alkenyl groups with terminal double bond in the molecule is selected from methylvinylsiloxanes, methylvinylsiloxane-dimethylsiloxane copolymers, dimethylpolysiloxanes with dimethylvinylsiloxy End groups, dimethylvinylsiloxy-terminated dimethylsiloxane-methylphenylsiloxane copolymers, dimethylvinylsiloxy-terminated dimethylsiloxane-diphenylsiloxane-methylvinylsiloxane copolymers, trimethylsiloxy-terminated dimethylsiloxane-methylvinylsiloxane copolymers, trimethylsiloxy-terminated dimethylsiloxane-methylphenylsiloxane-methylvinylsiloxane copolymers, Dimethylvinylsiloxy-terminated methyl- (3,3,3-trifluoropropyl) -polysiloxanes and dimethylvinylsiloxy-terminated dimethylsiloxane-methyl- (3,3,3-trifluoropropyl) -siloxane copolymers.

Crosslinking organopolysiloxanes having at least two silicon-bonded hydrogen atoms which are particularly preferred according to the invention are selected from trimethylsiloxy-terminated methylhydrogenpolysiloxanes, trimethylsiloxy-endblocked dimethylsiloxane-methylhydrogensiloxane copolymers and cyclic dimethylsiloxane-methylhydrogen-siloxane copolymers.

Silicone elastomers which are particularly preferred according to the invention and are already pre-swollen as raw material in a liquid at room temperature under normal conditions silicone and are a silicone-based gel are commercially available, for example under the trade name Dow Corning 9040 Silicone Elastomer Blend (a Cyclomethicone (and) Dimethicone Crosspolymer of Dow Corning; Silicone Elastomer Content 12-13% by Weight), SFE 168, a Cyclomethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer from GE Silicones, Vinyl Dimethicone Crosspolymers, contained in KSG-15 (Cyclomethicone (and) Dimethicone / Vinyl Dimethicone Crosspolymer, Silicone elastomer content 4 - 10 wt.%), KSG-16 (dimethicone (and) dimethicone / vinyl dimethicone crosspolymer, silicone elastomer content 20-30 wt.%), KSG-17 (cyclomethicone (and) dimethicone / vinyl dimethicone crosspolymer), KSG -18 (phenyl trimethicone (and) dimethicone / phenyl vinyl dimethicone crosspolymer, silicone elastomer content 10-20% by weight); and KSG-20 available from Shin Etsu Silicones of America (Akron, Ohio), and Grant Industries Inc. (Elmwood Park, NJ) products from the Gransil ^® series, especially Gransil SR-CYC (cyclomethicone and stearyl-vinyl / hydromethylsiloxane copolymer), Gransil RPS ^® gel (INCI name: Cyclopentasiloxane and Polysilicone-1 1), and ^® Gransil GCM-4 (INCI name: Polysilicone-cyclotetrasiloxane and 1 1) Gransil GCM-5 ^® (INCI name: Cyclopentasiloxane and Polysilicone-1 1), Gransil ^® RPS (INCI name: Cyclopentasiloxane and Polysilicone-1 1), GI-CD 10 (INCI name: Cyclopentasiloxane (and) Stearoxymethicone / Dimethicone copolymer (and) Dimethicone), Gransil ^® IDS (INCI name: Isododecane (and () cyclotetrasiloxane and) Polysilicone-1 1), Gransil ^® PC-12 (INCI name: Isododecane (and) Polysilicone-1 1), Gransil ^® IDS-5 (INCI name: Isododecane (and) (and) Cyclopentasiloxane polysilicone-1 1) Gransil ^® APK-1 (INCI name: Dimethi cone and Cyclopentasiloxane and Polysilicone-1 1 and nylon-12 and Methyl Methacrylate / Acrylonitrile copolymer and PEG-10 Dimethicone and Polysorbate-40 and Isohexadecane and ammonium Polyacryloyldimethyl taurates), Gransil ^® DMCM-5 (INCI name: Dimethicone and Cyclopentasiloxane and Polysilicone -1 1), Gransil DMG-6 ^® (with dimethicone 6 cSt) (INCI name: dimethicone and polysilicone-1 1), and ^® Gransil DMG-20 (Dimethicone with 20 cSt) (INCI name: Dimethicone and polysilicone-1 1), Gransil ^® AM-8 Gel (INCI name: Caprylyl Methicone and Cyclopentasiloxane and Polysilicone-1 1), Gransil ^® DM 5 (with Dimethicone 5 cst) (INCI name: dimethicone and polysilicone-1 1), Gransil ^® DMID (INCI designation: Dimethicone and Isododecane and Polysilicone-1 1), Gransil ^® PM (INCI name: phenyl Trimethicone and Polysilicone-1 1), Gransil ^® ININ (INCI name: isononyl Isononanoate (and ) Polysilicone-1 1).

Also useful in the compositions of the present invention are silicone elastomers already present as a raw material in a silicone liquid at room temperature under normal conditions, mixed with a non-silicone-containing oil, fat or wax, and a silicone / non-silicone based Pose gel. Such silicone elastomer compositions are also commercially available, for example under the trade name Gransil ^® MLB (INCI name: Cyclopentasiloxane and Polysilicone-1 1 and Beeswax), Gransil ^® PS (INCI name: cyclotetrasiloxane and polysilicone-1 1 and petrolatum), Gransil ^® PS-5 (INCI name: Cyclopentasiloxane and Polysilicone-1 1 and Petrolatum), Gransil ^® DMG-20 P with Dimethicone (20 cSt) and Petrolatum (INCI name: Dimethicone and Polysilicone-1 1 and Petrolatum), Gransil ^® RJO (INCI name: Cyclopentasiloxane and polysilicone-1 1 and Jojoba Oil), Gransil ^® LANO (INCI name: Cyclopentasiloxane and polysilicone-1 1 and lanolin), Gransil ^® OHS-5 (INCI name: Cyclopentasiloxane and polysilicone-1 1 and octyl hydroxystearate) and Gransil ^® DML (INCI designation: Dimethicone (and) neopentyl glycol Diheptanoate (and) Polysilicone-1 1).

A further preferred embodiment of the invention is characterized in that the silicone elastomer is obtainable by the crosslinking of an organopolysiloxane containing at least 2 C ₂ -C ₁₀ alkenyl groups having terminal double bonds in each molecule with at least one alpha, omega-diene. Crosslinking alpha, omega-dienes which are particularly preferred according to the invention have the formula CH ₂ = CH (CH ₂ ) x CH = CH ₂ where x = 1 to 20. Particularly preferred alpha, omega-dienes are selected from 1,4-pentadiene, 1,5-hexadiene, 1,6-heptadiene, 1,7-octadiene, 1,8-nonadiene, 1,1-dodecadiene, 1,13 Tetradecadiene and 1, 19-eicosadiene.

Compositions which are preferred according to the invention are characterized in that they contain at least one silicone elastomer in a total amount of 0.05-3% by weight, preferably 0.1-2% by weight, particularly preferably 0.2-1.0% by weight. , very preferably 0.3-0.5% by weight, based in each case on the total weight of the composition according to the invention.

As a wax solid under normal conditions, the composition according to the invention preferably additionally contains at least one polyethylene wax. Preferred polyethylene waxes have 30 to 60 carbon atoms.

Further preferred compositions according to the invention are characterized in that they contain at least one perfume and / or at least one perfume oil. As fragrances or perfume oils, individual perfume compounds, for example the synthetic products of the ester type, ethers, aldehydes, ketones, alcohols and hydrocarbons can be used. The phenolic fragrance compounds include z. B. carvacrol. Fragrance compounds of the ester type are, for example, benzyl acetate, methyl anthranilate, ortho-t-butylcyclohexyl acetate, p-tert-butylcyclohexyl acetate, diethyl phthalate, nonanediol-1,3-diacetate, isononyl acetate, isononylate, phenylethylphenylacetate, phenoxyethyl isobutyrate, linalyl acetate, Dimethylbenzylcarbinylacetate, phenylethylacetate, linalylbenzoate, benzylformate, ethylmethylphenylglycinate, allylcyclohexylpropionate, styrallylpropionate, benzylsalicylate, ethylsalicylate, iso-amylsalicylate, hexylsalicylate and 4-nonanolide. The ethers include, for example, benzyl ethyl ether, to the aldehydes, for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamen aldehyde, hydroxycitronellal, lilial and bourgeonal, to the ketones, for example, 6-acetyl-1, 1, 3,4,4,6-hexamethyltetrahydronaphthalene, para-t-amylcyclohexanone, 2-n-heptyl-cyclopentanone, β-methylnaphthyl ketone and the ionones α-isomethylionone and methyl cedryl ketone, to the alcohols cinnamyl alcohol, anethole, citronellol, dimyrcetol, eugenol, geraniol , Linalool, phenylethyl alcohol and terpineol, the hydrocarbons include 1, 3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylcyclopenta-a-2-benzopyran, hydroxymethylisopropylcyclopentane, 3 -α-methyldodecahydro-6,6,9a-trimethylnaphtho-2 (2, 1-b) furan, iso-butylquinoline and the terpenes and balsams. Preferably, mixtures of different fragrances are used, which together produce an attractive fragrance.

Suitable perfume oils may also contain natural fragrance mixtures such as are available from plant or animal sources, e.g. Pine, citrus, jasmine, rose, lily or ylang-ylang oil. Also, lower volatility volatile oils, which are most commonly used as aroma components, are useful as perfume oils, e.g. Sage oil, chamomile oil, lemon balm oil, mint oil, cinnamon leaf oil, lime blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, laudanum oil, clove oil, iso-eugenol, thyme oil, bergamot oil, geranium oil and rose oil.

Preferred compositions according to the invention comprise at least one perfume and / or at least one perfume oil in a total amount of 0.01-10% by weight, preferably 0.1-5% by weight, particularly preferably 0.5-3% by weight, extraordinarily preferably 1 to 2% by weight, in each case based on the total weight of the composition according to the invention.

Preferred compositions according to the invention are characterized in that they additionally contain at least one deodorant active ingredient. Preferred such deodorant active ingredients are selected from odor absorbers, deodorizing ion exchangers, germ-inhibiting substances, prebiotic substances and enzyme inhibitors and, particularly preferred, combinations of said deodorant active ingredients.

Silicates serve as odor absorbers, which at the same time advantageously support the rheological properties of the composition according to the invention. The silicates which are particularly advantageous according to the invention include, in particular, phyllosilicates and, among these, in particular morillonite, kaolinite, mit, beidellite, nontronite, saponite, hectorite, bentonite, smectite and talc. Further advantageous odor absorbers are, for example, zeolites, Zinkricinoleat, cyclodextrins, certain metal oxides, such as. As alumina, and chlorophyll.

According to the invention, germ-inhibiting or antimicrobial active ingredients are understood as meaning those active substances which reduce the number of skin germs participating in the formation of the odor or inhibit their growth. These organisms include, among others, various species from the group of staphylococci, the group of corynebacteria, anaerococci and micrococci.

Preferred antimicrobial or antimicrobial agents according to the invention are in particular organohalogen compounds and halides, quaternary ammonium compounds, a number of plant extracts and zinc compounds. These include triclosan, chlorhexidine and chlorhexidine gluconate, 3,4,4'-trichlorocarbanilide, bromochlorophene, dichlorophen, chlorothymol, chloroxylenol, hexachlorophene, dichloro-m-xylenol, dequalinium chloride, domiphenbromide, ammonium phenolsulfonate, benzalkonium halides, benzalkonium cetyl phosphate, benzalkonium saccharinates, Benzethonium chloride, cetylpyridinium chloride, laurylpyridinium chloride, laurylisoquinolinium bromide, methylbenzedonium chloride. Furthermore, phenol, disodium dihydroxyethylsulfosuccinone-undecylenate, sodium bicarbonate, zinc lactate, sodium phenolsulfonate and zinc phenol sulfonate, ketoglutaric acid, terpene alcohols such as. As farnesol, chlorophyllin copper complexes, a- monoalkyl glycerol ether with a branched or linear saturated or unsaturated, optionally hydroxylated C ₆ - C ₂₂ alkyl, particularly preferably a- (2-ethylhexyl) glycerol ether, commercially available as Sensiva ^® SC 50 (ex Schülke & Mayr), carboxylic acid esters of mono-, di- and triglycerol (eg glycerol monolaurate, diglycerol monocaprinate), lantibiotics and plant extracts (eg green tea and components of lime blossom oil).

Further preferred deodorant active substances are selected from so-called prebiotically active components, which according to the invention are to be understood as meaning those components which inhibit only or at least predominantly the odor-causing germs of the skin microflora, but not the desired ones, that is, the non-odor-forming germs that lead to a include healthy skin microflora. Explicitly here are the active ingredients, which are disclosed in the published patent applications DE 10333245 and DE 10 2004 01 1 968 as prebiotically effective, also included; these include conifer extracts, in particular from the group of Pinaceae, and plant extracts from the group of Sapindaceae, Araliaceae, Lamiaceae and Saxifragaceae, in particular extracts from Picea spp., Paullinia sp., Panax sp., Lamium album or Ribes nigrum and mixtures of these substances.

The enzyme inhibitors include substances which inhibit the enzymes responsible for the sweat decomposition, in particular arylsulfatase, β-glucuronidase, aminoacylase, esterases, lipases and / or lipoxigenase, e.g. B. trialkylcitric acid, in particular triethyl citrate, or zinc glycinate. Preferred compositions according to the invention are characterized in that the at least one additional deodorant active ingredient is selected from arylsulfatase inhibitors, β-glucuronidase inhibitors, aminoacylase inhibitors, esterase inhibitors, lipase inhibitors and lipoxygen inhibitors, α-monoalkyl glycerol ethers having a branched one or linear saturated or unsaturated, optionally hydroxylated C ₆ -C ₂ 2-alkyl radical, in particular a- (2-ethylhexyl) glycerol ether, prebiotic active compounds, trialkylcitric acid esters, in particular triethyl citrate, active compounds which contain the number of dermal nuclei from the group staphylococci, corynebacteria, anaerococci and micrococci reduce or inhibit their growth, zinc compounds, in particular zinc phenolsulfonate and zinc ricinoleate, organohalogen compounds, in particular triclosan, chlorhexidine, chlorohexane dingluconate and benzalkonium halides, quaternary ammonium compounds, in particular cetylpyridinium chloride, odor absorbers, in particular silicates and zeolites, sodium bicarbonate, lantibiotics, and mixtures of the abovementioned substances.

Further preferred compositions according to the invention are characterized in that the at least one additional deodorant active ingredient in a total amount of 0, 1 to 10 wt .-%, preferably 0.2 to 7 wt .-%, particularly preferably 0.3 to 5 wt. %, based on the total weight of the active substance in the total composition.

Antioxidant substances can counteract the oxidative decomposition of the welding components and in this way inhibit odor development. Suitable antioxidants are imidazole and imidazole derivatives (eg urocaninic acid), peptides such as e.g. B. D, L-carnosine, D-carnosine, L-carnosine and their derivatives (eg., Anserine), carotenoids, carotenes (eg, α-carotene, ß-carotene, lycopene) and their derivatives, lipoic acid and their derivatives (eg dihydrolipoic acid), aurothioglucose, propylthiouracil and other thio compounds (eg thioglycerol, thiosorbitol, thioglycolic acid, thioredoxin, glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl , Propyl, amyl, butyl, lauryl, palmitoyl, oleyl, γ-linoleyl, cholesteryl and glyceryl esters) and their salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and derivatives thereof (esters, ethers, peptides, lipids , Nucleotides, nucleosides and salts) as well as sulfoximine compounds (eg buthionine sulfoximines, homocysteine sulfoximine, buthione sulfones, penta, hexa, heptathionine sulfoximine) in very low tolerated dosages (eg pmol / kg to μΐηοΙ / kg), furthermore Metal chelators (eg, α-hydroxy fatty acids, EDTA, EGTA, lactofer rin), humic acids, bile acids, bile extracts, catechins, bilirubin, biliverdin and their derivatives, unsaturated fatty acids and their derivatives (eg. Gamma-linolenic acid, linoleic acid, arachidonic acid, oleic acid), folic acid and its derivatives, hydroquinone and its derivatives (eg arbutin), ubiquinone and ubiquinol and their derivatives, vitamin C and its derivatives (eg ascorbyl palmitate, stearate, dipalmitate, acetate, magnesium ascorbyl phosphates, sodium and magnesium ascorbate, disodium ascorbyl phosphate and sulfate, potassium ascorbyl tocopheryl phosphate, chitosan ascorbate), isoascorbic acid and its derivatives, tocopherols and their derivatives (for example tocopheryl acetate, linoleate, oleate and - succinate, tocophereth-5, tocophereth-10, tocophereth-12, tocophereth-18, tocophereth-50, Tocopherol), vitamin A and derivatives (e.g., vitamin A palmitate), the benzylic resin coniferyl benzoate, rutin, rutinic acid and derivatives thereof, disodium rubinyldisulfate, cinnamic acid and derivatives thereof, kojic acid, chitosan glycolate and salicylate, butylhydroxytoluene, butylated hydroxyanisole, Nordi hydroguaiacetic acid, nordihydroguiaretic acid, trihydroxybutyrophenone, uric acid and its derivatives, mannose and its derivatives, selenium and selenium derivatives (eg selenium methionine), stilbenes and stilbene derivatives (eg stilbene oxide, trans-stilbene oxide). According to the invention, suitable derivatives (salts, esters, sugars, nucleotides, nucleosides, peptides and lipids) as well as mixtures of said active substances or plant extracts containing these antioxidants can be used.

Preferred lipophilic, oil-soluble antioxidants from this group are tocopherol and its derivatives, in particular tocopheryl acetate, and carotenoids, as well as butylhydroxytoluene / anisole.

The total amount of antioxidants in preferred preparations according to the invention is 0.001-10% by weight, preferably 0.05-5% by weight and in particular 0.1-1% by weight, based on the total preparation.

Complex-forming substances can also support the deodorizing effect by stably complexing the catalytically active heavy metal ions (eg iron or copper). Suitable complexing agents are selected from the aforementioned complexing agents.

The following embodiments (A) to (J) according to the invention are very particularly preferred embodiments of the composition according to the invention:

(A): Solid, anhydrous composition in the form of a shaped body containing

at least one fatty alcohol having 12 to 18 carbon atoms,

at least one fatty alcohol with more than 18 carbon atoms,

at least one lactone compound of the formula I

wherein R is a hydrocarbon radical having 5 to 19 carbon atoms,

at least one oil,

at least one antiperspirant active ingredient.

(B): Solid, anhydrous composition, in particular in the form of a shaped body, each containing based on the total weight of the composition

at least one fatty alcohol having 12 to 18 carbon atoms,

at least one fatty alcohol with more than 18 carbon atoms,

at least one lactone compound of the formula I

wherein R is a hydrocarbon radical having 5 to 19 carbon atoms,

wherein the total amount of fatty alcohol having 12 to 18 carbon atoms is 12 to 25 wt .-%, in particular 15 to 20 wt .-%, and the total amount of fatty alcohol having more than 18 carbon atoms 0.005 to 1 wt .-%, in particular 0.05 to 0.2 wt .-%, is.

(C): Solid, anhydrous composition, in particular in the form of a shaped body, each containing based on the total weight of the composition

at least one fatty alcohol having 12 to 18 carbon atoms,

at least one fatty alcohol with more than 18 carbon atoms,

one or more lactone compounds of formula I in a total amount of 0.05 to 5.0 wt .-%, in particular 0, 1 to 0.5 wt .-%,

(I)

wherein R is a hydrocarbon radical having 5 to 19 carbon atoms,

(D): Solid, anhydrous composition, in particular in the form of a molding, each containing based on the total weight of the composition

at least one fatty alcohol having 12 to 18 carbon atoms,

at least one fatty alcohol with more than 18 carbon atoms,

wherein R is a hydrocarbon radical having 5 to 19 carbon atoms,

Oil, preferably in a total amount of from 25 to 80% by weight, particularly preferably from 30 to 70% by weight, very particularly preferably from 40 to 60% by weight,

wherein the total amount of fatty alcohol having 12 to 18 carbon atoms is 15 to 20% by weight, and the total amount of fatty alcohol having more than 18 carbon atoms is 0.005 to 1% by weight, in particular 0.05 to 0.2% by weight, is. (E): Solid, anhydrous composition, in particular in the form of a shaped body, each containing based on the total weight of the composition

at least one fatty alcohol having 12 to 18 carbon atoms,

at least one fatty alcohol with more than 18 carbon atoms,

one or more lactone compounds of the formula I in a total amount of from 0.05 to 5.0% by weight, in particular from 0.1 to 0.5% by weight,

wherein R is a hydrocarbon radical having 5 to 19 carbon atoms,

at least one volatile oil, preferably in a total amount of 25 to 80 wt .-%, particularly preferably from 30 to 70 wt .-%, most preferably from 30 to 55 wt.%, at least one non-volatile oil, preferably in a total amount from 0.1 to 25% by weight, in particular from 5 to 20% by weight

wherein the total amount of fatty alcohol having 12 to 18 carbon atoms is 15 to 20% by weight, and the total amount of fatty alcohol having more than 18 carbon atoms is 0.005 to 1% by weight, in particular 0.05 to 0.2% by weight, is.

(F): Solid, anhydrous composition, in particular in the form of a shaped body containing

at least one fatty alcohol having 12 to 18 carbon atoms,

at least one fatty alcohol with more than 18 carbon atoms,

at least one lactone compound of the formula I

wherein R is a hydrocarbon radical having 5 to 19 carbon atoms,

at least one antiperspirant active ingredient.

(G): Solid, anhydrous composition, in particular in the form of a shaped body, each containing based on the total weight of the composition

at least one fatty alcohol having 12 to 18 carbon atoms,

at least one fatty alcohol with more than 18 carbon atoms,

at least one lactone compound of the formula I

(I)

wherein R is a hydrocarbon radical having 5 to 19 carbon atoms,

at least one antiperspirant active, wherein the total amount of fatty alcohol having 12 to 18 carbon atoms is 12 to 25 wt .-%, in particular 15 to 20 wt .-%, and the total amount of fatty alcohol having more than 18 carbon atoms 0.005 to 1 wt .-%, in particular 0.05 to 0.2 wt .-%, is.

(H): Solid, anhydrous composition, in particular in the form of a shaped body, each containing based on the total weight of the composition

at least one fatty alcohol having 12 to 18 carbon atoms,

at least one fatty alcohol with more than 18 carbon atoms,

wherein R is a hydrocarbon radical having 5 to 19 carbon atoms,

at least one antiperspirant active,

(I): Solid, anhydrous composition, in particular in the form of a shaped body, each containing based on the total weight of the composition

at least one fatty alcohol having 12 to 18 carbon atoms,

at least one fatty alcohol with more than 18 carbon atoms,

wherein R is a hydrocarbon radical having 5 to 19 carbon atoms,

Oil, preferably in a total amount of 25 to 80 wt .-%, particularly preferably from 30 to

70% by weight, very particularly preferably from 40 to 60% by weight,

at least one antiperspirant active,

(J): Solid, anhydrous composition, in particular in the form of a molding, each containing based on the total weight of the composition

at least one fatty alcohol having 12 to 18 carbon atoms,

at least one fatty alcohol with more than 18 carbon atoms, one or more lactone compounds of the formula I in a total amount of from 0.05 to 5.0% by weight, in particular from 0.1 to 0.5% by weight,

wherein R is a hydrocarbon radical having 5 to 19 carbon atoms,

at least one non-volatile oil, preferably in a total amount of 0, 1 to 25 wt .-%, in particular from 5 to 20 wt .-%

at least one antiperspirant active,

For the embodiments (A) to (J), the aforementioned preferred embodiments (vide supra) of the features mentioned therein apply mutatis mutandis in turn as preferred.

A second object of the invention is a cosmetic product comprising

i) a dispensing device comprising

at least one container containing a piston which serves as a wall for the container and can be moved by a dispensing mechanism (in particular a nut and spindle arrangement),

at least one outlet opening in fluid communication with said container,

ii) a composition of the first subject of the invention located in said container.

The composition of the first subject of the invention can be dispensed from the exit port of the dispenser by actuation of the dispensing mechanism. In this case, the piston is moved and pressed the composition of the first subject of the invention in the direction of the outlet opening. By virtue of the resulting pressure, said composition is forced out of said dispenser through the at least one exit orifice.

A third object of the invention is the non-therapeutic use of a composition according to the first subject of the invention for reducing skin irritation.

A fourth object of the invention is the non-therapeutic use of a composition according to the first subject of the invention on irritated or sensitive skin. A fifth subject of the present application is the non-therapeutic use of the additional at least one antiperspirant active containing compositions of the first subject of the invention for reducing or masking body odor.

A sixth article is a non-therapeutic method for treating the skin in which a composition of the first subject of the invention is applied to the skin. The composition according to the invention particularly preferably remains on the skin for a time of 1 minute to 24 hours, preferably 2 to 12 hours.

A seventh subject matter of the present application is a non-therapeutic method of reducing or masking body odor, which comprises applying an additional at least one antiperspirant active composition of the first subject of the invention in an effective amount to the skin with a suitable applicator. The composition according to the invention particularly preferably remains on the skin for a time of 1 minute to 24 hours, preferably 2 to 12 hours.

A particularly preferred embodiment of the invention is characterized by the following points:

1. Solid, anhydrous composition, in particular in the form of a shaped body containing

at least one fatty alcohol having 12 to 18 carbon atoms,

at least one fatty alcohol with more than 18 carbon atoms,

at least one lactone compound of the formula I

wherein R is a hydrocarbon radical having 5 to 19 carbon atoms.

2. Composition according to item 1, characterized in that in addition at least one antiperspirant active ingredient is included.

3. Composition according to item 2, characterized in that antiperspirant active ingredient in a total amount of 3 to 35 wt .-%, preferably 5 to 30 wt .-% and particularly preferably 10 to 23 wt .-%, each based on the total weight the water-free active substance (USP) in the overall composition.

4. Composition according to one of the items 1 to 3, characterized in that they additionally contain at least one oil

5. The composition according to item 4, characterized in that, based in each case on the total weight of the composition, oil in a total amount of 25 to 80 wt .-%, particularly preferably from 30 to 70 wt .-%, most preferably from 40 to 60% by weight. Composition according to one of the items 4 or 5, characterized in that as oil at least one volatile oil is contained.

Composition according to item 6, characterized in that the volatile oil is at least one volatile silicone oil and / or at least one C ₈ -C ₁₆ iso-paraffin.

Composition according to any one of items 4 to 7, characterized in that it contains as an oil at least one compound of formula (II)

R '- (O-CH ₂ CHMe) _m -H (II)

wherein R 'is a (Ci-Ce) alkyl group and m is an integer from 5 to 20.

Composition according to one of the items 1 to 8, characterized in that the total amount of fatty alcohol in each case based on the total weight of the composition is greater than 10 wt .-%, in particular greater than 15 wt .-%, is.

Composition according to one of the items 1 to 9, characterized in that the total amount of fatty alcohol having 12 to 18 carbon atoms, in each case based on the total weight of the composition, is 12 to 25% by weight, in particular 15 to 20% by weight.

Composition according to any one of items 1 to 10, characterized in that fatty alcohol containing 12 to 18 carbon atoms refers to saturated fatty alcohol containing 12 to 18 carbon atoms.

Composition according to one of the items 1 to 1 1, characterized in that the total amount of stearyl alcohol, based on the total weight of the composition, 12 to 25 wt .-%, in particular 15 to 20 wt .-%, is.

Composition according to one of the items 1 to 12, characterized in that the total amount of fatty alcohol with more than 18 carbon atoms, based on the total weight of the composition, 0.005 to 1 wt .-%, in particular 0.05 to 0.2% by weight. , is.

Composition according to one of the items 1 to 13, characterized in that the weight ratio of the (especially solid) fatty alcohols having 12 to 18 carbon atoms to the (especially solid) fatty alcohols having more than 18 carbon atoms in a weight ratio range of 500 to 1 to 50 to 1, especially from 300 to 1 to 100 to 1

Composition according to one of the items 1 to 14, characterized in that the total amount of the compounds according to formula (I) based on the total weight of the composition, 0.05 to 5.0 wt .-%, in particular 0.1 to 0.5 wt .-%, is.

Cosmetic product comprising

i) a dispensing device comprising at least one container containing a piston which serves as a wall for the container and can be moved by a dispensing mechanism (in particular a nut and spindle arrangement),

at least one outlet opening in fluid communication with said container,

ii) a composition contained in said container according to any one of items 1 to 15.

16. Non-therapeutic use of a composition according to any one of items 1 to 15 for reducing skin irritation.

17. Non-therapeutic use of a composition according to any one of items 1 to 15 on irritated or sensitive skin.

The following examples are intended to illustrate the invention without limiting it thereto. Unless otherwise stated, all quantities are based on wt .-% based on the total weight of the corresponding composition.

B e i s p e e l e

The following solid compositions were prepared:

1 stearyl alcohol (INCI name: stearyl alcohol) (BASF SE)

2 Lorol® ^® C16 INCI name: Cetyl Alcohol (BASF SE)

3 arachidyl alcohol (Sasol)

4 INCI name: PPG-14 butyl ether (Dow)

5 lactone of 5-hydroxymeadowfoam fatty acids with the INCI name: Meadowfoam delta-lactones (Elementis)

6 INCI name: Coco Glycerides (BASF SE)

7 hydrogenated castor oil (INCI name: Hydrogenated Castor Oil) (BASF SE)

Compositions A to D were each prepared as a cylindrical antiperspirant stick. All pens had a creamy texture and could be applied to the site of action without irritating the skin.

Claims

Patent claims

at least one fatty alcohol having 12 to 18 carbon atoms,

at least one fatty alcohol with more than 18 carbon atoms,

at least one lactone compound of the formula I

wherein R is a hydrocarbon radical having 5 to 19 carbon atoms.

2. Composition according to claim 1, characterized in that in addition at least one antiperspirant active ingredient is included.

3. Composition according to one of claims 1 or 2, characterized in that they additionally contain at least one oil.

4. The composition according to claim 3, characterized in that in each case based on the total weight of the composition, oil in a total amount of 25 to 80 wt .-%, particularly preferably from 30 to 70 wt .-%, most preferably from 40 to 60 % By weight, is included.

5. Composition according to one of claims 1 to 4, characterized in that the total amount of fatty alcohol in each case based on the total weight of the composition is greater than 10 wt .-%, in particular greater than 15 wt .-%, is.

6. The composition according to any one of claims 1 to 5, characterized in that the total amount of fatty alcohol having 12 to 18 carbon atoms based on the total weight of the composition 12 to 25 wt .-%, in particular 15 to 20 wt .-%, is.

Composition according to any one of Claims 1 to 6, characterized in that fatty alcohol containing 12 to 18 carbon atoms refers to saturated fatty alcohol containing 12 to 18 carbon atoms.

8. The composition according to any one of claims 1 to 7, characterized in that the total amount of stearyl alcohol, based on the weight of the total composition, 12 to 25 wt .-%, in particular 15 to 20 wt .-%, is.

Composition according to any one of Claims 1 to 8, characterized in that the total amount of fatty alcohol containing more than 18 carbon atoms, relative to the Total weight of the composition, 0.005 to 1 wt .-%, in particular 0.05 to 0.2% by weight.

10. The composition according to any one of claims 1 to 9, characterized in that the total amount of the compounds according to formula (I) based on the total weight of the composition, 0.05 to 5.0 wt .-%, in particular 0.1 to 0, 5 wt .-%, is.